ClinicalTrials.gg
Not yet recruitingNCT07616804Updated Jun 1, 2026

Cognitive Responses to Acute Breath-Hold Diving Training in Female Divers

An interventional study of Land-Based Breath-Hold Training and Water-Based Breath-Hold Training in Sport Physiology and Cognitive Performance, sponsored by Istanbul Gelisim University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-01.

Sponsored by Istanbul Gelisim University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This study aims to investigate the acute cognitive and physiological responses to breath-hold diving training in trained female divers. Participants will complete three separate sessions including a control session, a land-based breath-hold training session, and a water-based breath-hold training session in randomized order. Cognitive performance, mood state, heart rate responses, respiratory function, and maximal breath-hold capacity will be evaluated before and after the interventions. The study is expected to improve understanding of how acute apnea-based diving exercises influence cognitive functions and physiological adaptations under different environmental conditions.

02

Conditions studied

  • Sport Physiology
  • Cognitive Performance
03

In context

Lead sponsor

Istanbul Gelisim University is the lead sponsor of 64 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Licensed breath-hold or free-diving athletes
  • Aged between 18 and 30 years
  • Minimum of 5 years of training experience
  • No known cardiovascular or pulmonary disease
  • Non-smokers
  • Willing to participate voluntarily
  • Refraining from intense exercise within 24 hours before testing

Exclusion criteria

Exclusion Criteria:

  • Use of performance-enhancing drugs or ergogenic aids
  • Presence of chronic sports injury
  • Alcohol consumption within 24 hours before testing
  • Caffeine intake within 2 hours before testing
  • Sleep deprivation or severe fatigue
  • Current medication use Fear of water or inability to complete breath-hold procedures
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Control Session

    Participants will complete baseline cognitive, respiratory, mood, and maximal breath-hold assessments without structured breath-hold exercise.

    Other: Control Session

  • Experimental
    Land-Based Breath-Hold Training

    Participants will perform land-based breath-hold exercises at 60% of individual maximal breath-hold capacity followed by post-intervention cognitive and mood assessments.

    Behavioral: Land-Based Breath-Hold Training

  • Experimental
    Water-Based Breath-Hold Training

    Participants will perform water-based breath-hold exercises in a swimming pool at 60% of individual maximal breath-hold capacity followed by post-intervention cognitive and mood assessments.

    Behavioral: Water-Based Breath-Hold Training

Interventions

  • BehavioralLand-Based Breath-Hold Training

    Participants will perform structured land-based breath-hold exercises consisting of repeated apnea efforts at 60% of individual maximal breath-hold capacity with standardized rest intervals.

  • BehavioralWater-Based Breath-Hold Training

    Participants will perform structured breath-hold exercises in a swimming pool environment consisting of repeated apnea efforts at 60% of individual maximal breath-hold capacity with standardized rest intervals.

  • OtherControl Session

    Participants will undergo baseline cognitive, respiratory, mood, and physiological assessments without structured apnea or breath-hold exercise intervention.

06

What researchers measure

Primary outcomes

  1. Working Memory Accuracy (2-Back Test)

    Accuracy score obtained from the computerized 2-back cognitive task.

    Time frame: Baseline and immediately after the intervention, within 5 minutes post-intervention.

  2. Reaction Time During the 2-Back Test

    Mean reaction time recorded during correct responses in the 2-back cognitive task.

    Time frame: Baseline and immediately after the intervention, within 5 minutes post-intervention.

Secondary outcomes

  1. Brunel Mood Scale (BRUMS) Total Score

    Total mood disturbance score assessed using the Brunel Mood Scale questionnaire.

    Time frame: Baseline and immediately after the intervention, within 5 minutes post-intervention.

  2. Maximum Breath-Hold Duration

    Maximum voluntary breath-hold duration recorded during testing.

    Time frame: Baseline during the control session before intervention sessions.

  3. Resting Heart Rate

    Resting heart rate measured before each session using a Polar heart rate monitor.

    Time frame: Before each experimental session.

  4. Exercise Heart Rate Response

    Heart rate responses recorded every 30 seconds during the breath-hold exercise protocol.

    Time frame: During the intervention session.

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2026; primary completion for Aug 2026, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
May 7, 2026
First posted
Jun 1, 2026
StartEst.
Jun 1, 2026
Primary completionEst.
Aug 30, 2026
CompletionEst.
Sep 15, 2026
Last update
Jun 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07616804
Lead sponsor
Istanbul Gelisim University
Responsible party
Görkem Açar (Ress. Asst., Istanbul Gelisim University) — Principal investigator
First posted
Jun 1, 2026
Start date
Jun 1, 2026 (estimated)
Primary completion
Aug 30, 2026 (estimated)
Completion
Sep 15, 2026 (estimated)
Last update
Jun 1, 2026

Study contacts

Görkem Açar, Ress. Asst.
Contact
gacar@gelisim.edu.tr
+90 545 407 01 98

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion